Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,368 INR | -1.26% | +5.98% | +13.63% |
May. 03 | INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh | RE |
May. 02 | Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4 | MT |
Sales 2024 | 42.09B 504M | Sales 2025 * | 47.29B 566M | Capitalization | 299B 3.59B |
---|---|---|---|---|---|
Net income 2024 | 8.16B 97.76M | Net income 2025 * | 9.46B 113M | EV / Sales 2024 | 6.67 x |
Net cash position 2024 * | 7.97B 95.48M | Net cash position 2025 * | 8.39B 100M | EV / Sales 2025 * | 6.16 x |
P/E ratio 2024 |
34.4
x | P/E ratio 2025 * |
32.1
x | Employees | 7,713 |
Yield 2024 * |
0.84% | Yield 2025 * |
0.75% | Free-Float | 50.31% |
Latest transcript on Ajanta Pharma Limited
1 day | -1.17% | ||
1 week | +6.09% | ||
Current month | +6.98% | ||
1 month | +10.98% | ||
3 months | +7.59% | ||
6 months | +31.58% | ||
Current year | +13.74% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 98-12-31 | |
Chief Executive Officer | 52 | 95-12-31 | |
Director of Finance/CFO | 59 | 98-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 95-12-31 | |
Chairman | 77 | 79-12-30 | |
Director/Board Member | 78 | 08-10-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +3.30% | - | |
0.00% | 0 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2,368 | -1.26% | 155 535 |
24-05-07 | 2,398 | -0.69% | 190,565 |
24-05-06 | 2,415 | +1.29% | 364,670 |
24-05-03 | 2,384 | +6.71% | 2,771,320 |
24-05-02 | 2,234 | +0.84% | 83,782 |
Delayed Quote NSE India S.E., May 08, 2024 at 05:22 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.74% | 3.59B | |
+20.43% | 43.57B | |
+20.70% | 22.7B | |
+16.52% | 14.32B | |
+11.10% | 13.42B | |
+45.89% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.33% | 5.51B |
- Stock Market
- Equities
- AJANTPHARM Stock